Literature DB >> 24556891

Variability of cognitive performance during hemodialysis: standardization of cognitive assessment.

Susanne Tholen1, Christoph Schmaderer, Ekatharina Kusmenkov, Stefan Chmielewski, Hans Förstl, Victoria Kehl, Uwe Heemann, Marcus Baumann, Timo Grimmer.   

Abstract

BACKGROUND/AIMS: Up to 70% of hemodialysis patients over the age of 54 have relevant cognitive impairment. No standardized protocol for the evaluation and monitoring of this population is available today. We hypothesized that the dialysis procedure and the testing environment induce fluctuations of cognitive performance.
METHODS: 26 hemodialysis patients were randomly tested using the Montreal Cognitive Assessment (MoCA) before, during and after hemodialysis and inside the dialysis room or alone in a separate room. Tests were performed at weekly intervals using five test variations to prevent learning effects. The Mini-Mental State Examination (MMSE) was performed as a reference test.
RESULTS: MoCA scores significantly differed between the conditions: 'before hemodialysis' revealed the best MoCA score as compared to 'during hemodialysis' or 'after hemodialysis' (p = 0.013). During the combined condition 'before dialysis AND separate room', best performance was achieved (p < 0.001). The BP decline had no significant influence on cognitive performance, whereas the fluid shift showed a significant impact (p = 0.008).
CONCLUSION: Cognitive performance in hemodialysis patients highly depends on the time point and testing environment. Therefore, we strongly suggest a standardization, using the MoCA before hemodialysis in a separate room, in order to make testing results of future research in this field comparable.

Entities:  

Mesh:

Year:  2014        PMID: 24556891     DOI: 10.1159/000357803

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  11 in total

1.  Advances in dialysis encephalopathy research: a review.

Authors:  Ying Chen; Xin Tian; Xuefeng Wang
Journal:  Neurol Sci       Date:  2018-05-02       Impact factor: 3.307

2.  The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.

Authors:  Frances E Tiffin-Richards; Ana S Costa; Bernhard Holschbach; Rolf D Frank; Athina Vassiliadou; Thilo Krüger; Karl Kuckuck; Theresa Gross; Frank Eitner; Jürgen Floege; Jörg B Schulz; Kathrin Reetz
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

3.  Rationale and study design of the prospective, longitudinal, observational cohort study "rISk strAtification in end-stage renal disease" (ISAR) study.

Authors:  Christoph Schmaderer; Susanne Tholen; Anna-Lena Hasenau; Christine Hauser; Yana Suttmann; Siegfried Wassertheurer; Christopher C Mayer; Axel Bauer; Kostantinos D Rizas; Stephan Kemmner; Konstantin Kotliar; Bernhard Haller; Johannes Mann; Lutz Renders; Uwe Heemann; Marcus Baumann
Journal:  BMC Nephrol       Date:  2016-10-26       Impact factor: 2.388

4.  Differential expression of serum biomarkers in hemodialysis patients with mild cognitive decline: A prospective single-center cohort study.

Authors:  Bin Zhu; Li-Na Jin; Jian-Qin Shen; Jin-Feng Liu; Ri-Yue Jiang; Ling Yang; Jie Zhang; Ai-Lin Luo; Li-Ying Miao; Chun Yang
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

5.  The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.

Authors:  Ru Tian; Yidan Guo; Pengpeng Ye; Chunxia Zhang; Yang Luo
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

6.  Assessment of cognitive impairment and related risk factors in hemodialysis patients.

Authors:  Hristos Karakizlis; Katharina Bohl; Jannis Ziemek; Richard Dodel; Joachim Hoyer
Journal:  J Nephrol       Date:  2021-10-16       Impact factor: 3.902

7.  Cognitive performance in dialysis patients - "when is the right time to test?"

Authors:  Hristos Karakizlis; Stefanie Thiele; Brandon Greene; Joachim Hoyer
Journal:  BMC Nephrol       Date:  2021-06-02       Impact factor: 2.388

8.  Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.

Authors:  Susanne Angermann; Marcus Baumann; Dominik Steubl; Georg Lorenz; Christine Hauser; Yana Suttmann; Anna-Lena Reichelt; Robin Satanovskij; Franziska Sonntag; Uwe Heemann; Timo Grimmer; Christoph Schmaderer
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

9.  Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms.

Authors:  Sun Hwa Lee; AJin Cho; Yang-Ki Min; Young-Ki Lee; San Jung
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

10.  Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol.

Authors:  Nicola Elzabeth Anderson; Melanie Calvert; Paul Cockwell; Mary Dutton; Olalekan Lee Aiyegbusi; Derek Kyte
Journal:  BMJ Open       Date:  2018-10-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.